Company intelligence / Profile preview

Lucerno Dynamics

Cary, North Carolina, USA

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Lucerno Dynamics is a medical technology company focused on improving the quality and safety of nuclear medicine procedures. The company's flagship product, the Lara System, is an FDA-cleared and CE-marked device designed to detect and monitor radiopharmaceutical extravasations in real-time. By providing clinicians with immediate feedback on the quality of tracer injections, Lucerno helps ensure the accuracy of PET and SPECT diagnostic imaging. The company is also a prominent advocate for regulatory changes to improve the reporting and management of injection-related medical events.

Therapeutic areas: Oncology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Lucerno Dynamics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucerno Dynamics.

Explore the full profile